Dulaglutide Dosage Chart: How Dosing Works

The Four Available Doses and What Each Is For

Dulaglutide, sold under the brand name Trulicity, is a once-weekly injectable GLP-1 receptor agonist used to help manage blood sugar in adults with type 2 diabetes. It comes in four approved dose strengths: 0.75 mg, 1.5 mg, 3 mg, and 4.5 mg. Understanding what each strength is intended for can help patients have more informed conversations with their care teams.

The 0.75 mg dose is the only strength approved for use as monotherapy, meaning it can be used on its own without additional diabetes medications. All three higher doses are intended to be used alongside other treatments. The 3 mg and 4.5 mg options were added to the lineup in 2020, expanding the original two-dose range and giving prescribers more flexibility for patients who need stronger glycemic control over time.

Standard Dose Escalation Schedule

Dulaglutide therapy typically follows a gradual step-up approach. Most patients begin at 0.75 mg or 1.5 mg once weekly and remain at that starting dose for a minimum of four weeks before any change is considered. This waiting period is intentional. It gives the body time to adjust and helps reduce the severity of common side effects like nausea and vomiting, which are most pronounced early in treatment.

If additional blood sugar control is needed after at least four weeks at 1.5 mg, a prescriber may increase the dose to 3 mg. The same four-week minimum applies before moving from 3 mg to the maximum dose of 4.5 mg. Not every patient will advance through all four levels. Some individuals find adequate control at a lower dose and stay there long-term.

Dosing Considerations for Special Populations

One practical advantage of dulaglutide is that most patients with mild to moderate kidney impairment do not require a dose adjustment. This sets it apart from several other diabetes medications that require careful renal dosing calculations. That said, clinical data on dulaglutide use in severe renal impairment or end-stage renal disease is limited, so extra caution applies in those situations.

For patients with liver impairment, formal dose adjustments are generally not required, though clinical experience in this population remains limited. Dulaglutide is not approved for patients under 18 years of age. Any patient with complex medical conditions, including kidney or liver disease, should work closely with their clinician to determine whether dulaglutide is appropriate and at what dose.

How and When to Inject Dulaglutide

Dulaglutide is administered as a subcutaneous injection, meaning it goes just under the skin rather than into a muscle. The three recommended injection sites are the abdomen, the thigh, and the upper arm. Rotating sites with each injection can help reduce skin irritation over time.

One of the more patient-friendly aspects of dulaglutide is its flexible timing. Injections are given on the same day each week, but the time of day does not need to stay consistent and the dose can be taken with or without food. The pre-filled single-dose pen does not require any manual needle attachment or dose dialing, making the process relatively straightforward for most people.

If a dose is missed, it can still be taken as long as the next scheduled dose is at least three days away. If less than three days remain before the next scheduled injection, the missed dose should be skipped and the regular weekly schedule resumed. Two doses should never be taken in the same week.

How Dulaglutide Dosing Compares to Other GLP-1 Medications

GLP-1 receptor agonists are not interchangeable, and comparing doses across different drugs requires important context. Dulaglutide and semaglutide (Ozempic) are both once-weekly injectables, while liraglutide (Victoza) requires a daily injection. The weekly schedule can support better adherence for some patients compared to daily options.

The maximum approved dose of dulaglutide is 4.5 mg weekly, while semaglutide's maximum injectable dose is 2 mg weekly. However, these numbers do not reflect a direct potency comparison. The two drugs work through similar mechanisms but are distinct molecules, so higher milligrams of one does not automatically mean a stronger effect than the other.

Another relevant difference is formulation. Semaglutide is available in an oral tablet form (Rybelsus) for patients who prefer to avoid injections. Dulaglutide does not currently have an oral option. For patients who are switching between GLP-1 agents or comparing options for the first time, a structured conversation with a clinician is the most reliable way to evaluate which drug and dose may be the best fit.

When a Dose Adjustment May Be Needed

Not every patient will move steadily up the escalation ladder, and some may need adjustments in the other direction. If nausea or vomiting persists beyond four weeks at a given dose, a prescriber may choose to hold off on escalation or temporarily step back to a lower dose level while the body continues to adapt.

When dulaglutide is combined with insulin or a sulfonylurea, the dose of those accompanying medications may need to be reduced to lower the risk of hypoglycemia. Dulaglutide itself has a low independent risk of causing low blood sugar, but that risk increases when combined with certain other agents.

Over time, meaningful changes in body weight or kidney function may also prompt a full reassessment of the diabetes treatment plan. Regular check-ins with a clinician help ensure that the current dose continues to match a patient's evolving health needs. Doctronic's platform, which has supported more than 22 million AI consultations with 99.2% treatment plan alignment with board-certified physicians, can be a useful first step for patients who have questions between appointments.

Frequently Asked Questions

What is the starting dose of dulaglutide for most patients?

Most patients begin dulaglutide at either 0.75 mg or 1.5 mg once weekly. The 0.75 mg dose is approved for use as a standalone therapy, while 1.5 mg is commonly chosen when dulaglutide is combined with other diabetes medications. Your prescriber will select the best starting point based on your individual health profile.

How long does it take to increase from 1.5 mg to 3 mg dulaglutide?

A minimum of four weeks at the 1.5 mg dose is required before a prescriber may consider increasing to 3 mg. This waiting period helps your body adjust and reduces the likelihood of nausea and other GI side effects. Not every patient will need or be recommended a dose increase after that window.

Can you take dulaglutide twice a week for better results?

No. Dulaglutide is approved only as a once-weekly injection. Taking it more frequently than prescribed is not recommended and may increase the risk of side effects without providing added benefit. If your current dose does not feel effective, speak with your clinician about whether a dose escalation is appropriate.

What happens if you miss a weekly dulaglutide injection?

If you miss a dose, you may take it as long as your next scheduled dose is at least three days away. If the next scheduled dose is sooner than three days, skip the missed dose and resume your normal weekly schedule. Do not take two doses in the same week to make up for a missed one.

Is the 4.5 mg dulaglutide dose more effective for weight loss than lower doses?

Clinical data suggests higher doses may support greater reductions in body weight, but individual responses vary. The 4.5 mg dose is the maximum approved strength and is typically reserved for patients who need additional glycemic control after tolerating lower doses. Weight-related goals should be discussed with your prescriber as part of your overall treatment plan.

The Bottom Line

Dulaglutide (Trulicity) follows a structured four-dose framework, starting at 0.75 mg or 1.5 mg and escalating gradually to a maximum of 4.5 mg weekly, with at least four weeks at each level before any increase. This careful step-up approach exists to protect patients from GI side effects while helping clinicians find the most effective dose. Decisions about whether to escalate, hold, or reduce your dose belong to a licensed clinician who knows your full health picture. Doctronic offers free AI consultations and $39 video visits, available 24/7, to help you better understand your prescription or discuss whether your current dose is working for you. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.